Indolealkylamine and phenalkylamine hallucinogens: a brief overview
- PMID: 6757811
- DOI: 10.1016/0149-7634(82)90030-6
Indolealkylamine and phenalkylamine hallucinogens: a brief overview
Abstract
Various indolealkylamine and phenalkylamine derivatives are hallucinogenic in man and/or are behaviorally active in animals. This overview is divided into two parts. The first part attempts to bring together information concerning the activity of indolealkylamines (i.e., tryptamines, alpha-methyltryptamines, N,N-dimethyltryptamines, N-alkyltryptamines, lysergic acid derivatives and beta-carbolines) and phenalkylamines (i.e., phenethylamines, phenylisopropylamines) along with major key references, and with emphasis on those agents not recently reviewed. The latter portion of this overview describes some of the work being conducted in our laboratories in an effort to elucidate the role of the neurotransmitter serotonin in the mechanism of action of various indolealkylamine and phenalkylamine hallucinogens.
Similar articles
-
A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.J Pharmacol Exp Ther. 1980 Aug;214(2):231-8. J Pharmacol Exp Ther. 1980. PMID: 6104720 No abstract available.
-
DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.Eur J Pharmacol. 1983 Jan 21;86(3-4):453-9. doi: 10.1016/0014-2999(83)90196-6. Eur J Pharmacol. 1983. PMID: 6572591
-
Psychotomimetic drugs: biochemistry and pharmacology.Adv Drug Res. 1973;7:165-206. Adv Drug Res. 1973. PMID: 4613150 Review. No abstract available.
-
Structure-activity-relationships of certain hallucinogenic substances based on brain levels.Life Sci. 1977 May 15;20(10):1629-35. doi: 10.1016/0024-3205(77)90335-6. Life Sci. 1977. PMID: 69244 Review. No abstract available.
-
The behavioral pharmacology of hallucinogens.Biochem Pharmacol. 2008 Jan 1;75(1):17-33. doi: 10.1016/j.bcp.2007.07.018. Epub 2007 Jul 20. Biochem Pharmacol. 2008. PMID: 17977517 Free PMC article. Review.
Cited by
-
The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.Psychopharmacology (Berl). 2006 Dec;189(3):319-29. doi: 10.1007/s00213-006-0566-1. Epub 2006 Sep 30. Psychopharmacology (Berl). 2006. PMID: 17013638
-
The rise (and fall?) of drug discrimination research.Drug Alcohol Depend. 2015 Jun 1;151:284-8. doi: 10.1016/j.drugalcdep.2015.04.001. Drug Alcohol Depend. 2015. PMID: 26207268 Free PMC article. No abstract available.
-
Modification of voltage-dependent gating of potassium channels by free form of tryptophan side chain.Biophys J. 2001 Jul;81(1):97-106. doi: 10.1016/S0006-3495(01)75683-4. Biophys J. 2001. PMID: 11423398 Free PMC article.
-
1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?Front Psychiatry. 2021 Dec 13;12:742856. doi: 10.3389/fpsyt.2021.742856. eCollection 2021. Front Psychiatry. 2021. PMID: 34966300 Free PMC article. Review.
-
Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.Neuropharmacology. 2013 Jul;70:218-27. doi: 10.1016/j.neuropharm.2013.01.014. Epub 2013 Jan 29. Neuropharmacology. 2013. PMID: 23376711 Free PMC article.